drugset / Trial / NCT02616068

Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma

NCT02616068

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the non-inferiority of the new transdermal patch dosage form containing loxoprofen sodium (100 mg - Daiichi-Sankyo) in comparison with oral Loxonin® (60 mg tablet - Daiichi-Sankyo) for the treatment of acute traumatic injuries.

Timeline

Start
2015-10
Primary completion
2016-12
Completion
2016-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Loxoprofen Small molecule 60 mg Other
Comparator Loxoprofen Small molecule 100 mg Other

Indications

No indication recorded.